Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Array-CGH analysis of cutaneous anaplastic large cell lymphoma.

Szuhai K, van Doorn R, Tensen CP, Van Kester.

Methods Mol Biol. 2013;973:197-212. doi: 10.1007/978-1-62703-281-0_13.

PMID:
23412792
2.

BCL2 and JUNB abnormalities in primary cutaneous lymphomas.

Mao X, Orchard G, Lillington DM, Child FJ, Vonderheid EC, Nowell PC, Bagot M, Bensussan A, Russell-Jones R, Young BD, Whittaker SJ.

Br J Dermatol. 2004 Sep;151(3):546-56.

PMID:
15377339
3.

Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations.

Zettl A, Rüdiger T, Konrad MA, Chott A, Simonitsch-Klupp I, Sonnen R, Müller-Hermelink HK, Ott G.

Am J Pathol. 2004 May;164(5):1837-48.

4.

Genetic alterations in primary cutaneous CD30+ anaplastic large cell lymphoma.

Mao X, Orchard G, Lillington DM, Russell-Jones R, Young BD, Whittaker S.

Genes Chromosomes Cancer. 2003 Jun;37(2):176-85.

PMID:
12696066
5.

CDKN2A-CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma.

Laharanne E, Chevret E, Idrissi Y, Gentil C, Longy M, Ferrer J, Dubus P, Jouary T, Vergier B, Beylot-Barry M, Merlio JP.

Mod Pathol. 2010 Apr;23(4):547-58. doi: 10.1038/modpathol.2009.196. Epub 2010 Jan 29.

6.

Cutaneous anaplastic large cell lymphoma and peripheral T-cell lymphoma NOS show distinct chromosomal alterations and differential expression of chemokine receptors and apoptosis regulators.

van Kester MS, Tensen CP, Vermeer MH, Dijkman R, Mulder AA, Szuhai K, Willemze R, van Doorn R.

J Invest Dermatol. 2010 Feb;130(2):563-75. doi: 10.1038/jid.2009.270. Epub 2009 Aug 27.

7.

Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome.

van Doorn R, van Kester MS, Dijkman R, Vermeer MH, Mulder AA, Szuhai K, Knijnenburg J, Boer JM, Willemze R, Tensen CP.

Blood. 2009 Jan 1;113(1):127-36. doi: 10.1182/blood-2008-04-153031. Epub 2008 Oct 1.

8.
9.

Chromosomal imbalances: a hallmark of tumour relapse in primary cutaneous CD30+ T-cell lymphoma.

Prochazkova M, Chevret E, Beylot-Barry M, Sobotka J, Vergier B, Delaunay M, Turmo M, Ferrer J, Kuglik P, Merlio JP.

J Pathol. 2003 Nov;201(3):421-9.

PMID:
14595754
10.

Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes.

Laharanne E, Oumouhou N, Bonnet F, Carlotti M, Gentil C, Chevret E, Jouary T, Longy M, Vergier B, Beylot-Barry M, Merlio JP.

J Invest Dermatol. 2010 Jun;130(6):1707-18. doi: 10.1038/jid.2010.8. Epub 2010 Feb 4.

11.

Heterogeneous abnormalities of CCND1 and RB1 in primary cutaneous T-Cell lymphomas suggesting impaired cell cycle control in disease pathogenesis.

Mao X, Orchard G, Vonderheid EC, Nowell PC, Bagot M, Bensussan A, Russell-Jones R, Young BD, Whittaker SJ.

J Invest Dermatol. 2006 Jun;126(6):1388-95.

12.

Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas.

Mao X, Orchard G, Lillington DM, Russell-Jones R, Young BD, Whittaker SJ.

Blood. 2003 Feb 15;101(4):1513-9. Epub 2002 Oct 3.

13.

Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sézary syndrome and mycosis fungoides.

Mao X, Lillington D, Scarisbrick JJ, Mitchell T, Czepulkowski B, Russell-Jones R, Young B, Whittaker SJ.

Br J Dermatol. 2002 Sep;147(3):464-75.

PMID:
12207585
14.

Telomerase functions beyond telomere maintenance in primary cutaneous T-cell lymphoma.

Chevret E, Andrique L, Prochazkova-Carlotti M, Ferrer J, Cappellen D, Laharanne E, Idrissi Y, Boettiger A, Sahraoui W, Ruiz F, Pham-Ledard A, Vergier B, Belloc F, Dubus P, Beylot-Barry M, Merlio JP.

Blood. 2014 Mar 20;123(12):1850-9. doi: 10.1182/blood-2013-05-500686. Epub 2014 Jan 27.

15.

[Anaplastic large cell lymphoma: an array-based comparative genomic hybridization study].

Wang M, Liu R, Su LY, Yu R, Gong LP.

Zhonghua Bing Li Xue Za Zhi. 2013 Sep;42(9):580-3. Chinese.

PMID:
24314241
16.

Chromosomal abnormalities in nodal and extranodal CD30+ anaplastic large cell lymphomas: infrequent detection of the t(2;5) in extranodal lymphomas.

Ott G, Katzenberger T, Siebert R, DeCoteau JF, Fletcher JA, Knoll JH, Kalla J, Rosenwald A, Ott MM, Weber-Matthiesen K, Kadin ME, Müller-Hermelink HK.

Genes Chromosomes Cancer. 1998 Jun;22(2):114-21.

PMID:
9598798
17.

Amplification of genomic DNA demonstrates the presence of the t(2;5) (p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis.

Sarris AH, Luthra R, Papadimitracopoulou V, Waasdorp M, Dimopoulos MA, McBride JA, Cabanillas F, Duvic M, Deisseroth A, Morris SW, Pugh WC.

Blood. 1996 Sep 1;88(5):1771-9.

18.

Th1 response and cytotoxicity genes are down-regulated in cutaneous T-cell lymphoma.

Hahtola S, Tuomela S, Elo L, Häkkinen T, Karenko L, Nedoszytko B, Heikkilä H, Saarialho-Kere U, Roszkiewicz J, Aittokallio T, Lahesmaa R, Ranki A.

Clin Cancer Res. 2006 Aug 15;12(16):4812-21.

19.
20.

Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas.

Salaverria I, Beà S, Lopez-Guillermo A, Lespinet V, Pinyol M, Burkhardt B, Lamant L, Zettl A, Horsman D, Gascoyne R, Ott G, Siebert R, Delsol G, Campo E.

Br J Haematol. 2008 Mar;140(5):516-26. doi: 10.1111/j.1365-2141.2007.06924.x.

PMID:
18275429

Supplemental Content

Support Center